ODDB.org: Open Drug Database

Swissmedic Registration	38096	Date of registration	27.06.1973
Company name	Roche Pharma (Schweiz) AG	Revision date	12.02.2004
		Valid until
Indication		Date of market entry
Index Therapeuticus (BSV)	01.08.	Revocation Date
Index Therapeuticus (Swissmedic)	01.08.	Information for professionals	IP

Seq.-No.	Product	Description	Galenic form	ATC-classification
01	Madopar 62.5	Kapseln	Capsules (Levodopa 50 mg, Benserazide 12.5 mg)	N04BA02	CI
02	Madopar 125	Kapseln	Capsules (Levodopa 100 mg, Benserazide 25 mg)	N04BA02	CI

2025	©ywesee GmbH